Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Invested Capital: 2022-2023

Historic Invested Capital for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $204.0 million.

  • Therapeutics' Invested Capital fell 35.53% to $204.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $204.0 million, marking a year-over-year decrease of 35.53%. This contributed to the annual value of $296.3 million for FY2022, which is N/A change from last year.
  • As of Q3 2023, Therapeutics' Invested Capital stood at $204.0 million, which was down 8.98% from $224.1 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Invested Capital registered a high of $361.3 million during Q1 2022, and its lowest value of $204.0 million during Q3 2023.
  • Moreover, its 2-year median value for Invested Capital was $296.3 million (2022), whereas its average is $288.1 million.
  • Data for Therapeutics' Invested Capital shows a maximum YoY tumbled of 35.53% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Therapeutics' Invested Capital stood at $296.3 million in 2022, then tumbled by 35.53% to $204.0 million in 2023.
  • Its last three reported values are $204.0 million in Q3 2023, $224.1 million for Q2 2023, and $276.2 million during Q1 2023.